Best Agrolife broadens patented range with overseas approvals

Best Agrolife Limited is expanding its product-led crop-protection strategy through three latest patented launches, a patent grant for a three-ingredient combination and 13 new domestic registrations in the quarter. Internationally, Best Agrolife completed a 47-metric-tonne shipment to Sudan, registered RONFEN™ in Nepal and secured one technical-product registration in Mexico.

Which patented products has Best Agrolife launched most recently?

Best Agrolife lists FLUZAM™, CUBAX POWER EXTRA™ and MIDCOTIN™ as its latest patented launches, covering groundnut, chilli and paddy. FLUZAM™ is an insecticide and fungicide formulation for groundnut containing trifloxystrobin 4%, fluxapyroxad 6.66% and clothianidin 25%; its listed targets include stem rot, collar rot, root rot, tikka leaf spot, rust, termites, thrips and white grubs.

CUBAX POWER EXTRA™ is a chilli insecticide containing spiromesifen 15%, hexythiazox 2.2% and abamectin 1.15%, targeting yellow mites and black thrips. MIDCOTIN™ is an insecticide and fungicide formulation for paddy with isoprothiolane 15%, trifloxystrobin 2.5% and pymetrozine 7.5%; the stated targets are sheath blight, blast, brown plant hopper and green leaf hopper.

These products add to a portfolio that the company overview describes as having more than 12 patented products. Earlier listed products include RONFEN™, labelled FY22-23 for brinjal, cotton and chilli; TRICOLOR™, labelled FY23-24 for tomato, paddy and apple; and BEST MAN™, labelled FY25-26 for okra and chilli.

What patent and domestic registrations did Best Agrolife secure?

Best Agrolife obtained a patent grant for the combination of fluxametamide, abamectin and trifloxystrobin and secured 13 new Central Insecticides Board registrations during the quarter. The presentation says the patent supports its focus on differentiated products, but it does not identify a marketed brand, crop or target pest for the three-ingredient combination.

The registration examples include a 9(3) FIM entry for Fluxametamide 5% plus Flonicamid 15% plus Abamectin 1.5% ME. The company also lists Fluxapyroxad 333g/l FS and Fluxametamide 10% w/w EC under 9(3) FIM vs FI, plus a 9(4) TIM registration for Cyclanilprole Technical 95.00% w/w minimum.

The 13 registrations are regulatory milestones rather than 13 named product launches. Best Agrolife separately presents the three latest patented products on its launch page, while the registration update records the patent grant and domestic approvals as part of the wider product-portfolio expansion.

How far has Best Agrolife progressed in overseas markets?

Best Agrolife has completed disclosed milestones in Sudan, Nepal and Mexico, while Taiwan and Sri Lanka remain in approval or testing stages. Sudan received a completed 47-metric-tonne shipment, and Nepal has registered RONFEN™, an insecticide containing pyriproxyfen 8%, dinotefuran 5% and diafenthiuron 18%.

In Nepal, four additional products have been submitted for registration, with management stating that approval is expected in the near future. In Mexico, Best Agrolife has secured registration for one technical product, identified by management as Lambda technical, while another technical-product registration is in progress.

Taiwan has one product at the final approval stage and a second progressing through review. In Sri Lanka, samples of two patented products are set for testing after initial approval, moving those products into the trial phase rather than completed commercial registration.

How did patented products relate to Best Agrolife’s FY27 results?

Best Agrolife reported that patented products accounted for 60% of branded sales in Q2 FY27, compared with 51% in Q2 FY26, as revenue from operations declined 21% to Rs 407 crore from Rs 517 crore. Management attributed the revenue decline to erratic rainfall, delayed sowing and lower crop-protection demand.

Over the same Q2 comparison, gross margin increased to 45% from 33%, while earnings before interest, tax, depreciation and amortisation, or EBITDA, rose 30% to Rs 101 crore from Rs 78 crore. Profit after tax increased 48% to Rs 57 crore from Rs 39 crore, and management linked margin expansion to the stronger patented portfolio, cost discipline and operational efficiency.

The H1 FY27 pattern was similar: revenue from operations declined 11% to Rs 803 crore from Rs 898 crore, while patented products rose to 63% of branded sales from 49%. Gross margin increased to 41% from 31%, EBITDA rose 45% to Rs 178 crore from Rs 123 crore, and profit after tax increased 67% to Rs 98 crore from Rs 59 crore.

Best Agrolife also reported operating-expense reductions following regional restructuring: 12% in Q2 FY27 compared with Q2 FY26 and 5% in H1 FY27 compared with H1 FY26. The company defines EBITDA in its reported figures as excluding other income.

Conclusion

Best Agrolife’s presentation shows a combined product and registration strategy: three latest patented launches and a new fluxametamide, abamectin and trifloxystrobin patent sit alongside 13 domestic registrations. The higher patented-product share of branded sales, rising to 60% in Q2 FY27 from 51%, coincided with gross-margin expansion despite a 21% decline in quarterly revenue.

Management says the second-half FY27 domestic outlook depends on Rabi sowing, soil moisture, irrigation availability and farmer spending on crop protection. The next disclosed international milestones are decisions on four Nepal submissions, a further Mexican technical-product registration, Taiwan’s final-stage approval and testing of two patented products in Sri Lanka.